Mercer Global Advisors
MDT icon

Mercer Global Advisors’s Medtronic MDT Stock Holding History

Mercer Global Advisors’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.5M Sell
504,928
-70,190
-12% -$5.66M 0.05% 216
2026
Q1 		$49.8M Sell
575,118
-5,725
-1% -$548K 0.07% 155
2025
Q4 		$63.3M Buy
580,843
+38,926
+7% +$3.78M 0.1% 126
2025
Q3 		$51.6M Buy
541,917
+126,172
+30% +$11.6M 0.09% 136
2025
Q2 		$38.6M Buy
415,745
+42,433
+11% +$3.6M 0.08% 141
2025
Q1 		$35.2M Buy
373,312
+96,031
+35% +$8.59M 0.08% 143
2024
Q4 		$22.1M Sell
277,281
-11,472
-4% -$993K 0.05% 195
2024
Q3 		$26.7M Buy
288,753
+159,197
+123% +$13.4M 0.06% 164
2024
Q2 		$10.4M Buy
129,556
+561
+0.4% +$46K 0.03% 294
2024
Q1 		$11.3M Buy
128,995
+20,932
+19% +$1.79M 0.03% 289
2023
Q4 		$8.9M Sell
108,063
-15,086
-12% -$1.15M 0.03% 328
2023
Q3 		$9.65M Sell
123,149
-37,849
-24% -$3.17M 0.04% 278
2023
Q2 		$14.2M Buy
160,998
+21,818
+16% +$1.88M 0.06% 221
2023
Q1 		$11.2M Buy
139,180
+17,242
+14% +$1.41M 0.05% 251
2022
Q4 		$9.48M Buy
121,938
+6,894
+6% +$559K 0.05% 276
2022
Q3 		$9.29M Buy
115,044
+5,094
+5% +$458K 0.06% 237
2022
Q2 		$9.87M Buy
109,950
+2,057
+2% +$208K 0.06% 226
2022
Q1 		$12M Buy
107,893
+10,438
+11% +$1.1M 0.07% 202
2021
Q4 		$10.1M Buy
97,455
+3,691
+4% +$427K 0.06% 233
2021
Q3 		$11.8M Sell
93,764
-665
-0.7% -$86.1K 0.08% 193
2021
Q2 		$11.7M Sell
94,429
-473
-0.5% -$59.4K 0.09% 169
2021
Q1 		$11.2M Buy
94,902
+3,898
+4% +$457K 0.1% 155
2020
Q4 		$10.7M Sell
91,004
-52,254
-36% -$5.75M 0.13% 117
2020
Q3 		$14.9M Sell
143,258
-6,952
-5% -$698K 0.22% 71
2020
Q2 		$13.8M Buy
150,210
+15,163
+11% +$1.45M 0.25% 64
2020
Q1 		$12.2M Buy
135,047
+37,575
+39% +$4M 0.27% 74
2019
Q4 		$11.1M Buy
97,472
+5,858
+6% +$643K 0.22% 92
2019
Q3 		$9.95M Buy
91,614
+13,651
+18% +$1.42M 0.23% 86
2019
Q2 		$7.59M Buy
77,963
+8,263
+12% +$754K 0.2% 102
2019
Q1 		$6.35M Buy
+69,700
New +$6.24M 0.23% 81

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Mercer Global Advisors's MDT Position: Q2 2026 in Review

Mercer Global Advisors reduced its Medtronic (MDT) stake by 12% in Q2 2026, selling an estimated $5.66M and leaving 504,928 shares worth $39.5M. The position accounts for 0.05% of the portfolio, ranked #216.

Mercer Global Advisors first reported a position in MDT in Q1 2019 and has held it in 30 quarters since. The position peaked at $63.3M in Q4 2025. 2,138 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Mercer Global Advisors held 504,928 shares of Medtronic worth $39.5M as of Q2 2026.
  • Mercer Global Advisors sold 70,190 Medtronic shares in Q2 2026, an estimated $5.66M.
  • Medtronic made up 0.05% of Mercer Global Advisors's portfolio in Q2 2026, its #216 holding.
  • Mercer Global Advisors first reported a position in Medtronic in Q1 2019 and has held it in 30 quarters since.
  • Mercer Global Advisors's Medtronic position peaked at $63.3M in Q4 2025.
  • 2,138 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.